Protection of beta cells against cytokine‐induced apoptosis by the gut microbial metabolite butyrate
The FEBS Journal · 2025
DOI: 10.1111/febs.17334 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Kasper Suhr Jørgensen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Apoptosis, Butyrates, Gastrointestinal Microbiome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: Novo Nordisk Fonden.
Abstract (Originalsprache)
Type 1 diabetes (T1D) is characterized by immune cell infiltration in the islets of Langerhans, leading to the destruction of insulin‐producing beta cells. This destruction is driven by secreted cytokines and cytotoxic T cells inducing apoptosis in beta cells. Butyrate, a metabolite produced by the gut microbiota, has been shown to have various health benefits, including anti‐inflammatory and anti‐diabetic effects. In this study, we investigated the potential protective effects of butyrate on cytokine‐induced apoptosis in beta cells and explored the underlying mechanisms. Insulin‐secreting INS‐1E cells and isolated mouse islets were treated with interleukin‐1beta (IL‐1β) or a combination of IL‐1β and interferon‐gamma (IFN‐γ) in the presence or absence of butyrate. We analyzed apoptosis, nitric oxide (NO) levels, expression of stress‐related genes, and immune cell migration. Our results demonstrated that butyrate significantly attenuated cytokine‐induced apoptosis in both INS‐1E cells and mouse islets, accompanied by a reduction in NO levels. Butyrate also decreased the expression of endoplasmic reticulum (ER) stress markers such as Chop , phosphorylated eIF2α and Atf4 , as well as some pro‐apoptotic genes including Dp5 and Puma . Butyrate reduced the cytokine‐induced expression of the chemokine genes Cxcl1 and Cxcl10 in mouse islets, as well as the chemotactic activity of THP‐1 monocytes toward conditioned media from IL‐1β‐exposed islets. In conclusion, these findings indicate that butyrate protects beta cells from cytokine‐induced apoptosis and ER stress, suggesting its potential as a therapeutic agent to prevent beta cell destruction in T1D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
ORCID-Profile: Nils Billestrup
Förderung
- Novo Nordisk Fonden
Zitieren
APA
Jørgensen, K. S., Pedersen, S. S., Hjorth, S. A., Billestrup, N., & Prause, M. (2025). Protection of beta cells against cytokine‐induced apoptosis by the gut microbial metabolite butyrate. The FEBS Journal. https://doi.org/10.1111/febs.17334
Vancouver
Jørgensen KS, Pedersen SS, Hjorth SA, Billestrup N, Prause M. Protection of beta cells against cytokine‐induced apoptosis by the gut microbial metabolite butyrate. The FEBS Journal. 2025. doi:10.1111/febs.17334
BibTeX
@article{Jrgensen2025,
author = {Jørgensen, Kasper Suhr and Pedersen, Signe Schultz and Hjorth, Siv Annegrethe and Billestrup, Nils and Prause, Michala},
title = {Protection of beta cells against cytokine‐induced apoptosis by the gut microbial metabolite butyrate},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.17334}
}
EUVIMED